Literature DB >> 32762907

Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel.

Jane E Wilcox1, James C Fang2, Kenneth B Margulies3, Douglas L Mann4.   

Abstract

Reverse left ventricular (LV) remodeling and recovery of LV function are associated with improved clinical outcomes in patients with heart failure with reduced ejection fraction. A growing body of evidence suggests that even among patients who experience a complete normalization of LV ejection fraction, a significant proportion will develop recurrent LV dysfunction accompanied by recurrent heart failure events. This has led to intense interest in understanding how to manage patients with heart failure with recovered ejection fraction (HFrecEF). Because of the lack of a standard definition for HFrecEF, and the paucity of clinical data with respect to the natural history of HFrecEF patients, there are no current guidelines on how these patients should be followed up and managed. Accordingly, this JACC Scientific Expert Panel reviews the biology of reverse LV remodeling and the clinical course of patients with HFrecEF, as well as provides guidelines for defining, diagnosing, and managing patients with HFrecEF.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  heart failure with recovered ejection fraction; myocardial recovery

Year:  2020        PMID: 32762907     DOI: 10.1016/j.jacc.2020.05.075

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  32 in total

Review 1.  Effects of SGLT2 inhibitors on cardiac structure and function.

Authors:  Giuseppina Novo; Tommaso Guarino; Daniela Di Lisi; Paolo Biagioli; Erberto Carluccio
Journal:  Heart Fail Rev       Date:  2022-06-16       Impact factor: 4.214

2.  Rapid recommendations: Updates from 2020 guidelines: part 1.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

3. 

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

4.  Improvement in cardiac function after renal transplantation in four patients with severe left ventricular systolic dysfunction.

Authors:  Emre Aslanger; Ayça Türer Cabbar; Burak Hünük; Mustafa Aytek Şimşek; Fırat Demircan; Süheyla Apaydın; Gürkan Tellioğlu; Muzaffer Murat Değertekin
Journal:  Anatol J Cardiol       Date:  2021-11       Impact factor: 1.596

5.  Foreword.

Authors: 
Journal:  Interv Cardiol       Date:  2022-06-29

Review 6.  Heart failure with mildly reduced ejection fraction: from diagnosis to treatment. Gaps and dilemmas in current clinical practice.

Authors:  Marta Cvijic; Yelena Rib; Suzana Danojevic; Crina Ioana Radulescu; Natia Nazghaidze; Panos Vardas
Journal:  Heart Fail Rev       Date:  2022-07-25       Impact factor: 4.654

7.  Implantable loop recorder as a strategy following cardiovascular implantable electronic device extraction without reimplantation.

Authors:  Antoinette Birs; Douglas Darden; Michael Eskander; Travis Pollema; Gordon Ho; Ulrika Birgersdotter-Green
Journal:  Pacing Clin Electrophysiol       Date:  2022-06-01       Impact factor: 1.912

Review 8.  LVAD as a Bridge to Remission from Advanced Heart Failure: Current Data and Opportunities for Improvement.

Authors:  Christos P Kyriakopoulos; Chris J Kapelios; Elizabeth L Stauder; Iosif Taleb; Rana Hamouche; Konstantinos Sideris; Antigone G Koliopoulou; Michael J Bonios; Stavros G Drakos
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

Review 9.  A Roadmap to Heart Regeneration Through Conserved Mechanisms in Zebrafish and Mammals.

Authors:  Kyla D Brezitski; Alexander W Goff; Paige DeBenedittis; Ravi Karra
Journal:  Curr Cardiol Rep       Date:  2021-03-02       Impact factor: 2.931

10.  Long-Term Trajectories of Left Ventricular Ejection Fraction in Patients With Chronic Inflammatory Diseases and Heart Failure: An Analysis of Electronic Health Records.

Authors:  Adovich S Rivera; Arjun Sinha; Faraz S Ahmad; Edward Thorp; Jane E Wilcox; Donald M Lloyd-Jones; Matthew J Feinstein
Journal:  Circ Heart Fail       Date:  2021-08-10       Impact factor: 10.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.